Newsfeeds Archive - Page 15 of 696

3 minute read

Y-mAbs Names Michael Rossi As President And Chief Executive Officer And Director

October 18, 4:06 PM

Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic

YMAB

2 minute read

MAIA Biotechnology To Present Latest Findings For Second Generation THIO Program At Turkish Biochemical Society’s International Biochemistry Congress 2023

By Happy Mohamed

October 17, 8:23 AM

MAIA Biotechnology, Inc. (NYSE:MAIA), a clinical stage company developing telomere-targeting immunotherapies for cancer, announced its participation in the International Biochemistry Congress 2023, organized by the

MAIA

2 minute read

Alignment Healthcare And Walgreens To Introduce Co-Branded Medicare Advantage Plans In Select Markets In 2024

By Happy Mohamed

October 17, 8:23 AM

Alignment Healthcare, Inc. (NASDAQ:ALHC) and Walgreens (NASDAQ:WBA) have signed an agreement to offer new $0-premium co-branded Medicare Advantage (MA) plans in select markets throughout Arizona,

ALHC

3 minute read

Prime Medicine To Highlight Preclinical Developments Across Prime Editing Pipeline And Platform At Upcoming Industry Conferences

By Happy Mohamed

October 17, 8:21 AM

Prime Medicine, Inc. (NASDAQ:PRME), a biotechnology company committed to delivering a new class of differentiated one-time curative genetic therapies, today announced that the Company will showcase advances in

PRME

3 minute read

Cellectar Biosciences Expands Commercialization Leadership Team Ahead Of Pivotal Data for Iopofosine I-131 in Waldenstrom’s Macroglobulinemia

By Happy Mohamed

October 17, 8:21 AM

William Yoon Appointed Vice President, Medical Affairs Aaditya Nanduri Appointed Vice President, Business Strategy and Analytics FLORHAM PARK, N.J., Oct. 17, 2023 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc.

CLRB

2 minute read

NKGen Biotech Presents Interim Phase I Trial Data At The XXVI World Congress Of Neurology Annual Meeting 2023

By Happy Mohamed

October 17, 8:20 AM

NKGen Biotech Inc. (NASDAQ:NKGN) ("NKGen" or the "Company"), a clinical-stage biotechnology company focused on the development and commercialization of innovative autologous, allogeneic, and CAR-NK

NKGN

2 minute read

News

Fresh Vine Wine, Inc. Submits Plan Of Compliance To NYSE American

By Happy Mohamed

October 17, 8:19 AM

Fresh Vine Wine, Inc. (NYSE:VINE) today announced that it has submitted a plan of compliance to NYSE American LLC ("NYSE American") addressing how the Company intends to regain compliance with NYSE

VINE

3 minute read

News

Society Pass Inc/Thoughtful Media Group Inc. Enters Philippines Market And Launches Creator Economy Focused Advertising Platform

By Happy Mohamed

October 17, 8:15 AM

SoPa officially launches Thoughtful Media Group (TMG), the leading digital advertising platform in Southeast Asia, in the Philippines market. TMG will present

SOPA

6 minute read

News

Microsoft Commences Private Exchange Offers And Activision Blizzard Commences Consent Solicitations

By Happy Mohamed

October 16, 4:21 PM

Microsoft Corporation (NASDAQ:MSFT) ("Microsoft") and Activision Blizzard, Inc. (NASDAQ:ATVI) ("Activision Blizzard") today announced that, in connection with the previously announced merger of

ATVI

2 minute read

Y-mAbs Announces Publication Of Naxitamab-Based Chemoimmunotherapy In Patients With Chemoresistant High-risk Neuroblastoma In The Journal Cancers

By Happy Mohamed

October 16, 4:08 PM

Y-mAbs Therapeutics, Inc. (the "Company" or "Y-mAbs") (NASDAQ:YMAB), a commercial-stage biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic

YMAB